Clinical Trial Update: A Confirmatory Trial of Adjunctive NAC to Prevent Post Tuberculosis Lung Disease [NA]

View source ↗

Summary

A confirmatory trial is evaluating adjunctive N-acetylcysteine to prevent post-tuberculosis lung disease; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: The Aurum Institute NPC | Conditions: Tuberculosis (TB) | NA | Status: RECRUITING